327 related articles for article (PubMed ID: 30862070)
1. Cancer Biogenesis in Ribosomopathies.
Sulima SO; Kampen KR; De Keersmaecker K
Cells; 2019 Mar; 8(3):. PubMed ID: 30862070
[TBL] [Abstract][Full Text] [Related]
2. Hallmarks of ribosomopathies.
Kampen KR; Sulima SO; Vereecke S; De Keersmaecker K
Nucleic Acids Res; 2020 Feb; 48(3):1013-1028. PubMed ID: 31350888
[TBL] [Abstract][Full Text] [Related]
3. Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy.
Kang J; Brajanovski N; Chan KT; Xuan J; Pearson RB; Sanij E
Signal Transduct Target Ther; 2021 Aug; 6(1):323. PubMed ID: 34462428
[TBL] [Abstract][Full Text] [Related]
4. Ribosomopathies and the paradox of cellular hypo- to hyperproliferation.
De Keersmaecker K; Sulima SO; Dinman JD
Blood; 2015 Feb; 125(9):1377-82. PubMed ID: 25575543
[TBL] [Abstract][Full Text] [Related]
5. How Ribosomes Translate Cancer.
Sulima SO; Hofman IJF; De Keersmaecker K; Dinman JD
Cancer Discov; 2017 Oct; 7(10):1069-1087. PubMed ID: 28923911
[TBL] [Abstract][Full Text] [Related]
6. Growth control and ribosomopathies.
Teng T; Thomas G; Mercer CA
Curr Opin Genet Dev; 2013 Feb; 23(1):63-71. PubMed ID: 23490481
[TBL] [Abstract][Full Text] [Related]
7. Ribosomopathies: how a common root can cause a tree of pathologies.
Danilova N; Gazda HT
Dis Model Mech; 2015 Sep; 8(9):1013-26. PubMed ID: 26398160
[TBL] [Abstract][Full Text] [Related]
8. Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance.
Elhamamsy AR; Metge BJ; Alsheikh HA; Shevde LA; Samant RS
Cancer Res; 2022 Jul; 82(13):2344-2353. PubMed ID: 35303060
[TBL] [Abstract][Full Text] [Related]
9. Impaired ribosome biogenesis: mechanisms and relevance to cancer and aging.
Turi Z; Lacey M; Mistrik M; Moudry P
Aging (Albany NY); 2019 Apr; 11(8):2512-2540. PubMed ID: 31026227
[TBL] [Abstract][Full Text] [Related]
10. Ribosomopathies and cancer: pharmacological implications.
Temaj G; Saha S; Dragusha S; Ejupi V; Buttari B; Profumo E; Beqa L; Saso L
Expert Rev Clin Pharmacol; 2022 Jun; 15(6):729-746. PubMed ID: 35787725
[TBL] [Abstract][Full Text] [Related]
11. Ribosomopathies: New Therapeutic Perspectives.
Orgebin E; Lamoureux F; Isidor B; Charrier C; Ory B; Lézot F; Baud'huin M
Cells; 2020 Sep; 9(9):. PubMed ID: 32932838
[TBL] [Abstract][Full Text] [Related]
12. Molecular etiology of defective nuclear and mitochondrial ribosome biogenesis: Clinical phenotypes and therapy.
Jerome MS; Nanjappa DP; Chakraborty A; Chakrabarty S
Biochimie; 2023 Apr; 207():122-136. PubMed ID: 36336106
[TBL] [Abstract][Full Text] [Related]
13. Translation defects in ribosomopathies.
Boussaid I; Fontenay M
Curr Opin Hematol; 2022 May; 29(3):119-125. PubMed ID: 35102070
[TBL] [Abstract][Full Text] [Related]
14. Nucleolar stress: From development to cancer.
Lafita-Navarro MC; Conacci-Sorrell M
Semin Cell Dev Biol; 2023 Feb; 136():64-74. PubMed ID: 35410715
[TBL] [Abstract][Full Text] [Related]
15. Ribosomopathies: There's strength in numbers.
Mills EW; Green R
Science; 2017 Nov; 358(6363):. PubMed ID: 29097519
[TBL] [Abstract][Full Text] [Related]
16. Eukaryotic Ribosome Assembly.
Baßler J; Hurt E
Annu Rev Biochem; 2019 Jun; 88():281-306. PubMed ID: 30566372
[TBL] [Abstract][Full Text] [Related]
17. The Nucleolus: A Multiphase Condensate Balancing Ribosome Synthesis and Translational Capacity in Health, Aging and Ribosomopathies.
Correll CC; Bartek J; Dundr M
Cells; 2019 Aug; 8(8):. PubMed ID: 31405125
[TBL] [Abstract][Full Text] [Related]
18. Probing the mechanisms underlying human diseases in making ribosomes.
Farley KI; Baserga SJ
Biochem Soc Trans; 2016 Aug; 44(4):1035-44. PubMed ID: 27528749
[TBL] [Abstract][Full Text] [Related]
19. Ribosomopathies: human disorders of ribosome dysfunction.
Narla A; Ebert BL
Blood; 2010 Apr; 115(16):3196-205. PubMed ID: 20194897
[TBL] [Abstract][Full Text] [Related]
20. The Ribosome Biogenesis-Cancer Connection.
Penzo M; Montanaro L; Treré D; Derenzini M
Cells; 2019 Jan; 8(1):. PubMed ID: 30650663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
